glioma
Conditions
Interventions
Microscopic observation fluorescence staining group (experimental group)
:None
Sponsors
The First Affiliated Hospital,Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. any gender, age 18-60 years old; 2. patients with a confirmed diagnosis of glioma (primary tumor or metastatic tumor) by imaging or biopsy; 3. patients who can tolerate the surgery by preoperative evaluation; the expected volume of tumor specimen to be resected intraoperatively is more than 1cm^3; 4. subjects who voluntarily enroll in the study, sign the informed consent form, and have a good adherence to the study and cooperate with the follow-up visits; 5. patients with expected survival of not less than 12 months as judged by clinician; and 6. patients who are not in the clinical trial. The expected survival period, as judged by the clinician, is not less than 12 months.
Exclusion criteria
Exclusion criteria: 1.Serious or unstable diseases of the heart, lungs, kidneys and hematopoietic system that cannot tolerate surgery; 2.Pregnant or lactating women; 3.Other factors that, in the judgment of the investigator, could lead to termination of the study, such as other serious medical conditions or serious laboratory abnormalities or other family or social factors that would affect the safety of the subject or the collection of test data and samples.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival (OS); | — |
Secondary
| Measure | Time frame |
|---|---|
| progression-free survival (PFS); | — |
Countries
China
Contacts
Public ContactZhang Nu
The First Affiliated Hospital,Sun Yat-sen University
Outcome results
None listed